Market Overview:
The global HIV/AIDS diagnostics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of HIV/AIDS, rising demand for early diagnosis and treatment, and technological advancements in HIV/AIDS diagnostics. The global HIV/AIDS diagnostics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into kits and reagents, instruments, and others. Kits and reagents held a major share of the global HIV/AIDS diagnostics market in 2017 owing to their low cost as compared to other types of diagnostic tests available in the market. Instruments are further sub-segmented into point-of-care testing (POCT) devices and laboratory instruments. POCT devices are expected to grow at a higher CAGR during the forecast period as they offer fast results with minimal sample preparation time as compared to laboratory instruments. By application, hospitals accounted for majority share of revenue generated by this market in 2017 owing to increased awareness about early diagnosis among patients visiting hospitals for various reasons such as routine checkups or treatment for other diseases or conditions unrelated to AIDS such as cancer or tuberculosis (TB).
Product Definition:
HIV/AIDS diagnostics is the process of detecting HIV infection and AIDS. It is used to determine a person's risk for developing AIDS, to monitor the effectiveness of treatment, and to assess the progress of disease.
Kits and Reagents:
Kits and reagents are the materials used by the diagnostic laboratories to perform an analysis. The factors that propel their growth include growing demand for rapid diagnostics, increasing prevalence of target diseases, rising government initiatives in healthcare sector and technological advancements in kits & reagents industry. On the other hand, there are also factors that hamper its growth such as stringent guidelines regarding usage of kits & reagents along with high cost associated with it which may affect patient’s budget.
Instruments:
Instruments are devices or systems used for obtaining, processing, analyzing and storing data in the form of results. It can be either portable or non-portable depending on the purpose.
Application Insights:
The others segment includes home testing kits, commercial/private diagnostic laboratories, and academic and research institutes. The others segment dominated the global market in terms of revenue in 2017. This is due to the increasing prevalence of HIV among adults as well as high unmet needs for diagnostics by these individuals. In addition, a rise in awareness about self-testing kits has led to an increase in their demand from private diagnostic laboratories across the world.
Hospitals were estimated to be the largest application segment owing to wide usage of HIV self-test kits at hospitals and clinics for diagnosis purposes along with continuous R&D initiatives by companies pertaining to introduction of advanced products for diagnosis at lower costs coupled with government support towards establishment of new laboratory facilities at hospitals is estimated to boost growth over forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high awareness levels coupled with the availability of effective treatment for HIV are some factors responsible for its large share. Moreover, increasing funding by government organizations and non-profit organizations is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to an increase in prevalence rates, growing patient awareness levels about early diagnosis as well as rising disposable income especially in developing countries such as India & China & Indonesia among others. Furthermore, a rise in investments by governments and private firms on R&D activities related to HIV diagnostics will boost revenue generation from this region over next eight years.
Growth Factors:
- Increasing incidence of HIV/AIDS: The global incidence of HIV is on the rise, with an estimated 36.7 million people living with the virus in 2016. This is expected to drive demand for diagnostic tests and therapies over the forecast period.
- Growing awareness about HIV/AIDS: There is a growing awareness about HIV/AIDS among both healthcare professionals and patients, which is likely to boost demand for diagnostics and treatment options over the forecast period.
- Technological advancements: Rapid technological advancements are taking place in the field of diagnostics, which is likely to result in increased adoption of novel diagnostic technologies over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
HIV/AIDS Diagnostics Market Research Report
By Type
Kits and Reagents, Instruments, Others
By Application
Hospitals, Private Diagnostic Laboratories, Academic and Research Institutes, Others
By Companies
Siemens Healthineers, Bio-Rad, Abbott Laboratories, OraSure Technologies, F. Hoffmann-La Roche, Hologic, Abbott, Chembio Diagnostic Systems, Becton, Dickinson and Company, Danaher Corporation(Cepheid)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
153
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global HIV/AIDS Diagnostics Market Report Segments:
The global HIV/AIDS Diagnostics market is segmented on the basis of:
Types
Kits and Reagents, Instruments, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Private Diagnostic Laboratories, Academic and Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens Healthineers
- Bio-Rad
- Abbott Laboratories
- OraSure Technologies
- F. Hoffmann-La Roche
- Hologic
- Abbott
- Chembio Diagnostic Systems
- Becton, Dickinson and Company
- Danaher Corporation(Cepheid)
Highlights of The HIV/AIDS Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Kits and Reagents
- Instruments
- Others
- By Application:
- Hospitals
- Private Diagnostic Laboratories
- Academic and Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HIV/AIDS Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HIV/AIDS Diagnostics is a term used to describe the various tests and procedures used to diagnose HIV infection. These tests can help doctors determine if someone has HIV, and can also help them track the progress of the virus over time.
Some of the key players operating in the hiv/aids diagnostics market are Siemens Healthineers, Bio-Rad, Abbott Laboratories, OraSure Technologies, F. Hoffmann-La Roche, Hologic, Abbott, Chembio Diagnostic Systems, Becton, Dickinson and Company, Danaher Corporation(Cepheid).
The hiv/aids diagnostics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 HIV/AIDS Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 HIV/AIDS Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 HIV/AIDS Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the HIV/AIDS Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global HIV/AIDS Diagnostics Market Size & Forecast, 2018-2028
4.5.1 HIV/AIDS Diagnostics Market Size and Y-o-Y Growth
4.5.2 HIV/AIDS Diagnostics Market Absolute $ Opportunity
Chapter 5 Global HIV/AIDS Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 HIV/AIDS Diagnostics Market Size Forecast by Type
5.2.1 Kits and Reagents
5.2.2 Instruments
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global HIV/AIDS Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 HIV/AIDS Diagnostics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Private Diagnostic Laboratories
6.2.3 Academic and Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global HIV/AIDS Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 HIV/AIDS Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America HIV/AIDS Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America HIV/AIDS Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America HIV/AIDS Diagnostics Market Size Forecast by Type
9.6.1 Kits and Reagents
9.6.2 Instruments
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America HIV/AIDS Diagnostics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Private Diagnostic Laboratories
9.10.3 Academic and Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe HIV/AIDS Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe HIV/AIDS Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe HIV/AIDS Diagnostics Market Size Forecast by Type
10.6.1 Kits and Reagents
10.6.2 Instruments
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe HIV/AIDS Diagnostics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Private Diagnostic Laboratories
10.10.3 Academic and Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific HIV/AIDS Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific HIV/AIDS Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific HIV/AIDS Diagnostics Market Size Forecast by Type
11.6.1 Kits and Reagents
11.6.2 Instruments
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific HIV/AIDS Diagnostics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Private Diagnostic Laboratories
11.10.3 Academic and Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America HIV/AIDS Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America HIV/AIDS Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America HIV/AIDS Diagnostics Market Size Forecast by Type
12.6.1 Kits and Reagents
12.6.2 Instruments
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America HIV/AIDS Diagnostics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Private Diagnostic Laboratories
12.10.3 Academic and Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) HIV/AIDS Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) HIV/AIDS Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) HIV/AIDS Diagnostics Market Size Forecast by Type
13.6.1 Kits and Reagents
13.6.2 Instruments
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) HIV/AIDS Diagnostics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Private Diagnostic Laboratories
13.10.3 Academic and Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 HIV/AIDS Diagnostics Market: Competitive Dashboard
14.2 Global HIV/AIDS Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siemens Healthineers
14.3.2 Bio-Rad
14.3.3 Abbott Laboratories
14.3.4 OraSure Technologies
14.3.5 F. Hoffmann-La Roche
14.3.6 Hologic
14.3.7 Abbott
14.3.8 Chembio Diagnostic Systems
14.3.9 Becton, Dickinson and Company
14.3.10 Danaher Corporation(Cepheid)
